Phase I Comparative Bioavailability Study

Study identifier:D0810C00024

ClinicalTrials.gov identifier:NCT00777582

EudraCT identifier:2008-003697-18

CTIS identifier:N/A

Recruitment Complete

Official Title

A Phase I, Randomised, 2 Period Cross Over Study to Determine the Comparative Bioavailability of Two Different Oral Formulations of AZD2281 in Cancer Patients with Advanced Solid Tumours

Medical condition

Solid Tumors

Phase

Phase 1

Healthy volunteers

No

Study drug

AZD2281

Sex

All

Actual Enrollment

197

Study type

Interventional

Age

18 Years - 130 Years

Date

Study Start Date: 27 Oct 2008
Primary Completion Date: 06 Feb 2009
Estimated Study Completion Date: 31 Mar 2025

Study design

Allocation: Randomized
Endpoint Classification: Bio-availability Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Dec 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria